HTF Market
Intelligence released a new research report of 25 pages on title 'Xbrane
Biopharma AB (XBRANE) - Financial and Strategic SWOT Analysis Review' with detailed analysis, forecast and
strategies.
Summary
Xbrane Biopharma AB (Xbrane), formerly known as Xbrane
Bioscience AB, is a biopharmaceutical company that develops and manufactures
complex generics. The company's product portfolio includes biosimilars and
generic drugs developed for people suffering from critical diseases. It
combines its proprietary microsphere and protein production technology
platforms to develop and produce generics drugs for controlled release of the
active substance through encapsulation in microspheres. The company’s products
find application in treating diseases across various therapeutic areas
including acromegaly and neuroendocrine tumours, prostate cancer, endometriosis
and uterine fibroids; age-related macular degeneration and macular oedema and
among others. Xbrane is headquartered in Stockholm, Sweden.
Xbrane Biopharma AB Key Recent Developments
May 04,2017: Xbrane Biopharma recruits CFO and Head of
Investor Relations
Feb 27,2017: Xbrane Biopharma releases 2016 Year End
Report
Feb 17,2017: Xbrane Biopharma obtains GMP certification
for Spherotide production facility
Dec 23,2016: Xbrane Biopharma appoints Anders P. Wiklund
as strategic advisor
Nov 21,2016: Xbrane Biopharma Releases Interim Report For
The Period July-September 2016
This comprehensive SWOT profile of Xbrane Biopharma AB
provides you an in-depth strategic analysis of the company’s businesses and
operations. The profile has been compiled by GlobalData to bring to you a clear
and an unbiased view of the company’s key strengths and weaknesses and the
potential opportunities and threats. The profile helps you formulate strategies
that augment your business by enabling you to understand your partners,
customers and competitors better.
This company report forms part of GlobalData’s ‘Profile
on Demand’ service, covering over 50,000 of the world’s leading companies. Once
purchased, GlobalData’s highly qualified team of company analysts will
comprehensively research and author a full financial and strategic analysis of
Xbrane Biopharma AB including a detailed SWOT analysis, and deliver this direct
to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information
including*,
- Business description – A detailed description of the
company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the
company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s
strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated
with the company.
- Major products and services – A list of major products,
services and brands of the company.
- Key competitors – A list of key competitors to the
company.
- Key employees – A list of the key executives of the
company.
- Executive biographies – A brief summary of the
executives’ employment history.
- Key operational heads – A list of personnel heading key
departments/functions.
- Important locations and subsidiaries – A list and
contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing
facilities of the company.
- Detailed financial ratios for the past five years – The
latest financial ratios derived from the annual financial statements published
by the company with 5 years history.
- Interim ratios for the last five interim periods – The
latest financial ratios derived from the quarterly/semi-annual financial
statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is
unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its
operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure,
operations, major products and services, prospects, locations and subsidiaries,
key executives and their biographies and key competitors.
Understand and respond to your competitors’ business
structure and strategies, and capitalize on their weaknesses. Stay up to date
on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas
of development or decline are analyzed and presented in the profile
objectively. Recent developments in the company covered in the profile help you
track important events.
Equip yourself with information that enables you to
sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit
are sized up and its growth potential assessed in the profile. Competitive
and/or technological threats are highlighted.
Scout for potential investments and acquisition targets,
with detailed insight into the companies’ strategic, financial and operational
performance.
- Financial ratio presented for major public companies in
the profile include the revenue trends, profitability, growth, margins and
returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or
business research.
- Key elements such as SWOT analysis, corporate strategy
and financial ratios and charts are incorporated in the profile to assist your
academic or business research needs.
Make an enquiry
before buying this Report @ https://www.htfmarketreport.com/enquiry-before-buy/407843-xbrane-biopharma-ab-3
Table of Contents
Section 1 - About
the Company
Xbrane Biopharma
AB - Key Information
Xbrane Biopharma
AB - Overview
Xbrane Biopharma
AB - Key Employees
Xbrane Biopharma
AB - Key Employee Biographies
Xbrane Biopharma
AB - Key Operational Heads
Xbrane Biopharma
AB - Major Products and Services
Xbrane Biopharma
AB - History
Xbrane Biopharma
AB - Company Statement
Xbrane Biopharma
AB - Locations And Subsidiaries
Xbrane Biopharma
AB - Key Manufacturing facilities
Head Office
Other Locations
& Subsidiaries
Section 2 -
Company Analysis
Xbrane Biopharma
AB - Business Description
Xbrane Biopharma
AB - Corporate Strategy
Xbrane Biopharma
AB - SWOT Analysis
SWOT Analysis -
Overview
Xbrane Biopharma
AB - Strengths
Xbrane Biopharma
AB - Weaknesses
Xbrane Biopharma
AB - Opportunities
Xbrane Biopharma
AB - Threats
Xbrane Biopharma
AB - Key Competitors
Section 3 -
Company Financial Performance Charts
Xbrane Biopharma
AB - Financial Ratios
Financial Ratios -
Capital Market Ratios
Financial Ratios -
Annual Ratios
Financial Ratios -
Interim Ratios
Financial Ratios -
Ratio Charts
Section 4 -
Appendix
Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Note*: Some
sections may be missing if data is unavailable for the company List of Tables
Xbrane Biopharma
AB, Key Information
Xbrane Biopharma
AB, Key Ratios
Xbrane Biopharma
AB, Share Data
Xbrane Biopharma
AB, Major Products and Services
Xbrane Biopharma
AB, History
Xbrane Biopharma
AB, Key Employees
Xbrane Biopharma
AB, Key Employee Biographies
Xbrane Biopharma
AB, Key Operational Heads
Xbrane Biopharma
AB, Other Locations
Xbrane Biopharma
AB, Subsidiaries
Xbrane Biopharma
AB, Key Manufacturing facilities
Xbrane Biopharma
AB, Key Competitors
Xbrane Biopharma
AB, SWOT Analysis
Xbrane Biopharma
AB, Ratios based on current share price
Xbrane Biopharma
AB, Annual Ratios
Xbrane Biopharma
AB, Interim Ratios
Currency Codes
Capital Market
Ratios
Equity Ratios
Profitability
Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Xbrane Biopharma
AB, Performance Chart
Xbrane Biopharma AB,
Ratio Charts
Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=407843
Contact Us:
CRAIG FRANCIS (PR
& Marketing Manager)
sales@htfmarketreport.com
Ph:
+1 (206) 317 1218
No comments:
Post a Comment